AnalystsDane LeoneDane Leone's Stock Forecasts
AnalystsDane Leone
Analyst Ranking
Bottom 4%
#4382 out of 4554 analysts
Average Return
-12.69%
Win Rate
31%20 out of 65
Risk vs Reward
Poor
Good
Dane Leone's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nkarta IncNKTX | +214.11% | $2.48 | $7.79 | 2023-06-27 - 2024-04-18 | Buy |
Nkarta IncNKTX | +156.25% | $3.04 | $7.79 | 2023-10-17 - 2024-04-18 | Strong Buy |
Nkarta IncNKTX | +148.09% | $3.14 | $7.79 | 2023-10-17 - 2024-04-18 | Strong Buy |
Kite Pharma IncKITE | +105.43% | $86.67 | $178.05 | 2017-06-07 - 2017-08-28 | Strong Buy |
Blueprint Medicines CorpBPMC | +95.28% | $46.22 | $90.26 | 2023-02-16 - 2024-02-16 | Strong Buy |
Dane Leone Analyst Color
Get additional color on Dane Leone's coverage of popular stocks
Dane Leone's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regenxbio IncRGNX | 2 | Buy | $45.00 | +179.33% | Reinstates | 2 months ago |
Blueprint Medicines CorpBPMC | 4 | Strong Buy | $100.00 | +12.49% | Maintains | 4 months ago |
Revolution Medicines IncRVMD | 1 | Buy | $30.00 | -16.27% | Initiates Coverage On | 5 months ago |
Bluebird Bio IncBLUE | 5 | Buy | $13.00 | +1,264.11% | Maintains | 5 months ago |
Regeneron Pharmaceuticals IncREGN | 5 | Buy | $950.00 | +6.27% | Upgrades | 6 months ago |
LianbioLIANY | 3 | Buy | $9.00 | +2,721.32% | Maintains | 6 months ago |
Nkarta IncNKTX | 5 | Strong Buy | $13.00 | +66.88% | Upgrades | 6 months ago |
Bridgebio Pharma IncBBIO | 2 | Buy | $46.00 | +84.37% | Maintains | 9 months ago |
Galapagos NvGLPG | 4 | Buy | $69.00 | +138.67% | Upgrades | a year ago |
G1 Therapeutics IncGTHX | 4 | Buy | $8.00 | +91.85% | Maintains | a year ago |
Relay Therapeutics IncRLAY | 2 | Strong Buy | $29.00 | +374.63% | Upgrades | a year ago |
Seagen IncSGEN | 3 | Strong Buy | $175.00 | N/A | Upgrades | a year ago |
Compass Therapeutics IncCMPX | 2 | Buy | $8.00 | N/A | Maintains | a year ago |
Xilio Therapeutics IncXLO | 2 | Buy | $13.00 | N/A | Maintains | a year ago |
Ocular Therapeutix IncOCUL | 3 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Xencor IncXNCR | 2 | Strong Buy | $58.00 | N/A | Upgrades | 2 years ago |
Simulations Plus IncSLP | 2 | Buy | $70.00 | N/A | Maintains | 2 years ago |
Allogene Therapeutics IncALLO | 5 | Hold | N/A | N/A | Downgrades | 2 years ago |
Cytokinetics IncCYTK | 2 | Buy | $63.00 | N/A | Maintains | 2 years ago |
Bristol Myers Squibb CoBMY | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Ayala Pharmaceuticals IncAYLA | 2 | Buy | $6.00 | N/A | Maintains | 2 years ago |
Curis IncCRIS | 1 | Buy | $300.00 | N/A | Initiates Coverage On | 3 years ago |
Tarsus Pharmaceuticals IncTARS | 2 | Strong Buy | $65.00 | N/A | Maintains | 3 years ago |
Sage Therapeutics IncSAGE | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Amgen IncAMGN | 3 | Buy | $255.00 | N/A | Upgrades | 3 years ago |
Celgene CorpCELG | 2 | Hold | N/A | N/A | Assumes | 5 years ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | $32.00 | N/A | Assumes | 6 years ago |
Kite Pharma IncKITE | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Johnson & JohnsonJNJ | 1 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Juno Therapeutics IncJUNO | 1 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.